Business Description
Rhoen Klinikum AG
ISIN : DE0007042301
Share Class Description:
XTER:RHK: Ordinary SharesCompare
Compare
Traded in other countries / regions
RHK.GermanyRHKJF.USA0NQH.UKRHK.Austria IPO Date
1989-11-27Description
Rhoen Klinikum AG provides medical care focused in five key areas: cardiovascular medicine, neuromedicine, oncology, pulmonary diseases, and orthopedic and trauma surgery. The firm operates in three business areas: acute hospitals, medical care centers, and rehabilitation hospitals. The acute hospitals business contributes to the vast majority of the firm's overall revenue. The majority of patients at the firm's acute hospitals and medical care centers are treated on an outpatient basis. Rhoen Klinikum generates the entirety of its revenue in Germany, with the Bavaria and Hesse regions contributing the largest proportions of revenue.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 3.93 | |||||
| Equity-to-Asset | 0.7 | |||||
| Debt-to-Equity | 0.12 | |||||
| Debt-to-EBITDA | 1.24 | |||||
| Interest Coverage | 13.23 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 2.33 | |||||
| Beneish M-Score | -2.4 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 2.5 | |||||
| 3-Year EBITDA Growth Rate | 13 | |||||
| 3-Year FCF Growth Rate | 41.4 | |||||
| 3-Year Book Growth Rate | 2.4 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 8.4 | |||||
| Future 3-5Y Total Revenue Growth Rate | 5.27 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 57.04 | |||||
| 9-Day RSI | 62.2 | |||||
| 14-Day RSI | 62.73 | |||||
| 6-1 Month Momentum % | 0.8 | |||||
| 12-1 Month Momentum % | 21.15 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.35 | |||||
| Quick Ratio | 2.26 | |||||
| Cash Ratio | 1.56 | |||||
| Days Inventory | 23.06 | |||||
| Days Sales Outstanding | 55.35 | |||||
| Days Payable | 44.58 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -7.17 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 65.66 | |||||
| Operating Margin % | 2.83 | |||||
| Net Margin % | 2.9 | |||||
| FCF Margin % | 2.99 | |||||
| ROE % | 3.56 | |||||
| ROA % | 2.49 | |||||
| ROIC % | 2.83 | |||||
| ROC (Joel Greenblatt) % | 7.53 | |||||
| ROCE % | 4.09 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 20.6 | |||||
| Forward PE Ratio | 21.9 | |||||
| PE Ratio without NRI | 21.4 | |||||
| Shiller PE Ratio | 18.02 | |||||
| Price-to-Owner-Earnings | 51.11 | |||||
| PS Ratio | 0.6 | |||||
| PB Ratio | 0.72 | |||||
| Price-to-Tangible-Book | 0.83 | |||||
| Price-to-Free-Cash-Flow | 20 | |||||
| Price-to-Operating-Cash-Flow | 8.48 | |||||
| EV-to-EBIT | 12.3 | |||||
| EV-to-EBITDA | 6 | |||||
| EV-to-Revenue | 0.47 | |||||
| EV-to-FCF | 15.75 | |||||
| Price-to-Projected-FCF | 1.04 | |||||
| Price-to-Median-PS-Value | 0.61 | |||||
| Price-to-Graham-Number | 0.89 | |||||
| Price-to-Net-Current-Asset-Value | 2.85 | |||||
| Price-to-Net-Cash | 31.36 | |||||
| Earnings Yield (Greenblatt) % | 8.13 | |||||
| FCF Yield % | 4.97 | |||||
| Forward Rate of Return (Yacktman) % | 2.89 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Rhoen Klinikum AG Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 1,546.077 | ||
| EPS (TTM) (€) | 0.67 | ||
| Beta | -0.1 | ||
| Volatility % | 37.68 | ||
| 14-Day RSI | 62.73 | ||
| 14-Day ATR (€) | 0.246253 | ||
| 20-Day SMA (€) | 13.325 | ||
| 12-1 Month Momentum % | 21.15 | ||
| 52-Week Range (€) | 9.5 - 14 | ||
| Shares Outstanding (Mil) | 66.94 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Rhoen Klinikum AG Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Rhoen Klinikum AG Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Rhoen Klinikum AG Frequently Asked Questions
What is Rhoen Klinikum AG(XTER:RHK)'s stock price today?
The current price of XTER:RHK is €13.80. The 52 week high of XTER:RHK is €14.00 and 52 week low is €9.50.
When is next earnings date of Rhoen Klinikum AG(XTER:RHK)?
The next earnings date of Rhoen Klinikum AG(XTER:RHK) is 2025-02-07 Est..
Does Rhoen Klinikum AG(XTER:RHK) pay dividends? If so, how much?
Rhoen Klinikum AG(XTER:RHK) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers